← Leaderboards
Margaret Mary Chou
University Of Pennsylvania
$5,151,189
Attributed
$5,151,189
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $484.8K · FY2005–21$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,151,189 · 4
By mechanism
R01$4,303,369 · 2
R21$847,820 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- James L Riley$56,591,102
- Arjun Raj$12,538,737
- Jennifer Elizabeth Phillips-Cremins$16,516,249
- Carl H. June$35,377,952
- Bruce J Shenker$14,692,911
Others in their field
Top investigators on “Cell Proliferation”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- David Heimbrook · Leidos Biomedical Research, Inc.$103,164,048
- Timothy J Eberlein · Washington University$49,931,668
- Deirdre R. Meldrum · University Of Washington$37,202,510
- Robert A Weinberg · Whitehead Institute For Biomedical Res$32,735,166
Research focus
Cell ProliferationTranscription FactorTumorigenesisMediatingPathway InteractionsCarcinomaIn VitroCellsMolecularMalignant NeoplasmsIn VivoSignal TransductionRecurrenceSamplingTumorNeoplasm MetastasisBaseOncologyMalignant - DescriptorCell SurvivalMouse ModelInsightMediator Of Activation ProteinPathogenesis
Grant awards (19)
Pathogenic mechanisms of sinonasal sarcoma, a novel gender dimorphic cancer$205,700
R21 · FY2021 · CA · contact PI
Pathogenic mechanisms of sinonasal sarcoma, a novel gender dimorphic cancer$246,840
R21 · FY2020 · CA · contact PI
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6$259,058
R01 · FY2017 · CA · contact PI
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6$259,058
R01 · FY2016 · CA · contact PI
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6$261,619
R01 · FY2015 · CA · contact PI
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6$258,230
R01 · FY2014 · CA · contact PI
Pathogenic mechanisms of alveolar rhabdomyosarcoma$176,692
R21 · FY2014 · CA · contact PI
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6$266,216
R01 · FY2013 · CA · contact PI
Pathogenic mechanisms of alveolar rhabdomyosarcoma$218,588
R21 · FY2013 · CA · contact PI
TRE17 links actin remodeling & vesicle trafficking$331,448
R01 · FY2009 · CA · contact PI
TRE17 links actin remodeling & vesicle trafficking$302,838
R01 · FY2008 · CA · contact PI
TRE17 links actin remodeling & vesicle trafficking$306,354
R01 · FY2007 · CA · contact PI
TRE17 links actin remodeling & vesicle trafficking$315,894
R01 · FY2006 · CA · contact PI
TRE17 links actin remodeling &vesicle trafficking$323,884
R01 · FY2005 · CA
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42$300,774
R01 · FY2004 · CA
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42$292,010
R01 · FY2003 · CA
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42$283,507
R01 · FY2002 · CA
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42$275,248
R01 · FY2001 · CA
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42$267,231
R01 · FY2000 · CA